Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MEDPACK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.9% 1.9%   Bankruptcy risk   8.1% 7.8% 3.3% 2.3% 1.6% 1.3% 10.0% 10.0%   Credit score (0-100)   32 32 54 63 74 79 25 25   Credit rating   BB BB BBB BBB A A BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 4.8 34.2 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   965 625 1,116 1,688 1,567 1,572 0.0 0.0   EBITDA   159 63.3 639 1,013 761 618 0.0 0.0   EBIT   115 29.6 639 1,013 755 591 0.0 0.0   Pre-tax profit (PTP)   85.3 -13.6 632.9 1,011.2 752.6 597.4 0.0 0.0   Net earnings   63.6 -11.1 493.3 795.2 585.1 463.0 0.0 0.0   Pre-tax profit without non-rec. items   84.4 -13.6 633 1,011 753 597 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   64.6 0.0 0.0 0.0 129 102 0.0 0.0   Shareholders equity total   194 183 543 1,139 1,374 1,487 1,037 1,037   Interest-bearing liabilities   123 255 0.0 0.0 182 0.0 0.0 0.0   Balance sheet total (assets)   1,131 1,015 1,610 2,541 2,225 2,289 1,037 1,037   Net Debt   123 255 -682 -537 182 -383 -1,037 -1,037     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   965 625 1,116 1,688 1,567 1,572 0.0 0.0   Gross profit growth   7.4% -35.2% 78.5% 51.3% -7.2% 0.3% -100.0% 0.0%   Employees   2 2 2 2 2 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   1,131 1,015 1,610 2,541 2,225 2,289 1,037 1,037   Balance sheet change%   -0.4% -10.2% 58.6% 57.8% -12.4% 2.8% -54.7% 0.0%   Added value   159.0 63.3 639.2 1,012.9 754.5 618.1 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -89 -98 0 0 123 -54 -102 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   11.9% 4.7% 57.3% 60.0% 48.2% 37.6% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   10.1% 2.8% 48.7% 48.9% 31.8% 26.6% 0.0% 0.0%   ROI %   22.3% 7.8% 126.6% 118.8% 56.2% 39.4% 0.0% 0.0%   ROE %   30.6% -5.9% 135.8% 94.6% 46.6% 32.4% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   17.2% 18.0% 33.7% 44.8% 61.7% 65.0% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   77.5% 402.7% -106.8% -53.0% 23.9% -62.0% 0.0% 0.0%   Gearing %   63.4% 139.2% 0.0% 0.0% 13.2% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   9.9% 22.8% 4.9% 0.0% 6.2% 4.3% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   0.8 0.7 1.1 1.4 1.6 1.7 0.0 0.0   Current Ratio   1.1 1.2 1.5 1.8 2.4 2.7 0.0 0.0   Cash and cash equivalent   0.0 0.0 682.4 537.1 0.0 383.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   112.3 166.3 555.0 1,121.6 1,188.9 1,323.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   80 32 320 506 377 309 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   80 32 320 506 380 309 0 0   EBIT / employee   57 15 320 506 377 296 0 0   Net earnings / employee   32 -6 247 398 293 231 0 0